These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits. Sugrue MF, O'Neill-Davis L. J Ocul Pharmacol; 1991 Jan 21; 7(3):201-11. PubMed ID: 1783853 [Abstract] [Full Text] [Related]
73. Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressure. Huang Q, Rui EY, Cobbs M, Dinh DM, Gukasyan HJ, Lafontaine JA, Mehta S, Patterson BD, Rewolinski DA, Richardson PF, Edwards MP. J Med Chem; 2015 Mar 26; 58(6):2821-33. PubMed ID: 25728019 [Abstract] [Full Text] [Related]
74. 2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. Chiaramonte N, Bua S, Ferraroni M, Nocentini A, Bonardi A, Bartolucci G, Durante M, Lucarini L, Chiapponi D, Dei S, Manetti D, Teodori E, Gratteri P, Masini E, Supuran CT, Romanelli MN. Eur J Med Chem; 2018 May 10; 151():363-375. PubMed ID: 29635168 [Abstract] [Full Text] [Related]
76. Ocular hypertension. II. A carbonic anhydrase inhibitor test for early detection of glaucoma. Linnér E. Acta Ophthalmol (Copenh); 1978 Apr 10; 56(2):179-90. PubMed ID: 580840 [Abstract] [Full Text] [Related]
80. Fabrication of acetazolamide loaded leciplex for intraocular delivery: Optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics. Bagul US, Khot SV, Ashtekar KS, Monde AA, Kolhe OH, Tagalpallewar AA, Kokare CR. Int J Pharm; 2024 Aug 15; 661():124391. PubMed ID: 38936444 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]